BioSpace News Archive

Genetown

ClearLine MD Secures $5.5MM Funding for Commercialization of ClearLine IV™

The funding represents continued support from Rosse Enterprises.

January 9, 2018
·
2 min read
Business

Pfizer Backs and Inks $162M+ Deal With Tiny Adapsyn Bioscience

Founded in 2016, Adapsyn is focused on the R&D of novel medicines derived from evolved small molecule natural products.

January 9, 2018
·
3 min read
Business

BeiGene and Boehringer Ingelheim Announce Commercial Supply Agreement for Anti-PD-1 Antibody Tislelizumab

Tislelizumab will be manufactured in Boehringer Ingelheim’s world-class biopharmaceutical manufacturing facility in Shanghai.

January 9, 2018
·
6 min read
Business

Histogenics Corporation Announces Receipt of $10M Up-front Payment for Japanese Neocart Agreement

Histogenics and MEDINET announced entering into the agreement in December 2017.

January 9, 2018
·
5 min read
Genetown

BC Platforms to Provide Big Data Driven Research Solutions to Amgen in Cardiovascular Diseases and Oncology

BC Platforms today announces that Amgen Finland will be using its technology solutions and research platform, including BCRQUEST.COM.

January 9, 2018
·
2 min read
Drug Development

Rebiotix Highlights 2017 Achievements and 2018 Objectives

Rebiotix provided a review of its 2017 key business achievements and clinical activities as the company anticipates multiple milestones during 2018 involving its industry-leading MRT drug platform.

January 9, 2018
·
4 min read
Zika Virus Vaccine Shows Significantly Higher Immune Response With Needle-Free Delivery

PharmaJet announced that a recently published study in The Lancet demonstrated that delivery of a Zika virus vaccine with the PharmaJet Stratis.

January 9, 2018
·
2 min read
Business

Cingulate Therapeutics Appoints Experienced Lead Investigator Matthew Brams, MD as CMO

Dr. Brams is a Co-Founder of Cingulate Therapeutics and currently serves as a member of the Board of Directors.

January 9, 2018
·
3 min read
Pharm Country

Creative Diagnostics Launches Epigenetics Antibodies for Bio-research Communities

Now highly specific antibodies are available at Creative Diagnostics to most histone modifications validated in CHIP.

January 9, 2018
·
2 min read
Medtronic Enrolls First Patient In Pain Study to Assess Optimized Spinal Cord Stimulation Programming

The first patient was enrolled by The Center for Interventional Pain & Spine in Wilmington, Delaware.

January 9, 2018
·
6 min read